Skip to main content
SHAZ logo

SHAZ · SharonAI Holdings Inc. · Metrics

Track SHAZ — free
$26.97 -0.07 (-0.26%) At close · Oct 20
Market Cap
$968.13M
Shares
35.80M
Volume · Oct 20 2.03M Avg daily vol (3M) 1.9M

SHAZ metrics

59 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$26.97
Market cap
$968.13M

Price action

20 metrics
Price change (1W)
-22.3%
Price change (30D)
-55.0%
Price change (3M)
-62.0%
Price change (6M)
-30.8%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
123.5%
Annualized volatility (3M)
122.3%
Beta
3.6
RSI (14D)
21.9
Price vs SMA 50
-49.1%
Price vs SMA 200
—
Avg volume (3M)
1.90M
Relative volume
1.1
Average dollar volume
$99.17M

Company

3 metrics
Sector
Technology
Industry
Information Technology Services
Shares outstanding
35.80M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
313.3×
reciprocal yield 0.3%
P / book
0.9
reciprocal yield 116.5%
FCF yield
-0.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
43.4
reciprocal yield 2.3%
Earnings yield
-50.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
33.9%
Operating margin
-1,217.4%
Trailing 12 months
Net margin
-15,658.3%
Gross profit (TTM)
$1.05M
Operating profit (TTM)
−$37.62M
Net income (TTM)
−$483.83M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-37.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+412.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.09M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+93.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-42.9%
Return on assets
-20.8%
Debt / equity
—
Current ratio
10.6
EBITDA (TTM)
−$33.17M
Free cash flow (TTM)
−$1.14M
Quick ratio
10.6
Interest coverage
-10.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.86B
Latest balance sheet
Cash & equivalents
$1.86B
Total assets
$2.32B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$22.31M
Capital expenditures (TTM)
$23.46M
R&D (TTM)
—
SG&A (TTM)
$22.73M
Stock compensation (TTM)
$3.86M
R&D / revenue
—
Stock compensation / revenue
124.8%

Ownership (13F)

9 metrics
13F filers
117
13F filer change QoQ
+86
Institutional ownership
54.4%
Conviction holders (share of 13F filers)
7.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+261.6%
Holder tenure
1.7
Price vs estimated holder cost
+68.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.6%

Short interest

3 metrics
Short interest
7.8%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 2068385 CUSIP 778920306 13F (30d) 11 filings 11 filers Visit website Investor relations